Sources: EQT Partners to team with Actavis in Ratiopharm bid

EQT Partners AB, the last private-equity bidder for German generic-drug maker Ratiopharm GmbH, is seeking to team up with Actavis Group to bolster its chances of beating large pharmaceutical companies like Pfizer in the auction, said three people familiar with the matter. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.